FDA Inspection 1341700 — CG Bio Co., Ltd.
The FDA completed an inspection of CG Bio Co., Ltd. on Sep 3, 2026 in Hwaseong. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 3, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Hwaseong (Korea (the Republic of))